03.04.25 -- New AAV Reference Standards To Aid CQA Assessment

A proactive approach to packaging development can ultimately ensure a smoother launch. Explore five key considerations when selecting components for your injectable drug product.

Learn how AI, powered by quality data and real-time monitoring, is accelerating production and bringing life-saving treatments to more patients.

Advancements in recombinant protein production have improved efficiency and quality. However, optimizing cell culture media remains crucial to ensure maximized yield and desirable product attributes.

Join UCL experts in exploring how advanced perfusion techniques and stirred-tank bioreactors can enhance CAR-T cell manufacturing with improved yields, scale-up, and reduced costs.

We developed and validated a dual screening procedure (genotype and phenotype) for Lonza human peripheral blood mononuclear cells (PBMCs) to identify donors with high ADCC potential.

Sterile connectors streamline cell and gene therapy processes while maintaining sterility. By withstanding extreme temperatures and cryoprotectants, they can ensure product viability during cryopreservation.

Gain insight into the modest origins of cell therapy manufacturing and how this history has paved the way for future advancements from Bill Shingleton, R&D Leader at Cytiva.

Explore guidance on the materials and methods recommended for assembling a perfusion system using a 60 Micron Plastic (PE) Retention Filter with a Vertical-Wheel Bioreactor.

A growing number of AAV product developers are recognizing the value in moving to suspension as early in development as possible in order to optimize production.